GoodRx is teaming up with Sanofi to offer consumers access to its most prescribed insulin, Lantus, for $35 at thousands of pharmacies nationwide. All Americans with a valid prescription, regardless of ...
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its ...
GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced it has earned its 2026 ...
GoodRx is a core integration partner for TrumpRx, powering the pricing for leading brand medicationsAt launch, GoodRx is the integrated pricing source on TrumpRx for Pfizer, including over 30 of ...
The all-in-one solution includes a virtual consultation, clinically proven prescription medication, and discreet home delivery, starting as low as $16/month Hair loss is one of the most common health ...
While waiting in line to pick up a prescription, you’ve probably noticed those little yellow and white business cards at the pharmacy counter offering savings—and wondered if they’re legitimate. With ...
GoodRx Holdings Inc. (NASDAQ:GDRX), a leading healthcare technology company specializing in prescription drug discounts and telehealth services, finds itself at a critical juncture. As the company ...
In March of this year the three largest insulin manufacturers announced a dramatic reduction in the price of many commonly prescribed insulins and a monthly out-of-pocket (OOP) cap of $35 that went ...
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results